Sale

Aortic Valve Replacement Devices Market

Global Aortic Valve Replacement Devices Market Size, Share, Forecast: By Surgery Type: Open Surgery, Minimally Invasive Surgery; By Product Type: Transcatheter Aortic Valve, Sutureless Aortic Valve Replacement (SUAVR); By End User: Hospitals, Ambulatory Surgical Centres, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Aortic Valve Replacement Devices Market Size

The global aortic valve replacement devices market size reached a value of USD 8.99 billion in 2023. The market is estimated to witness a CAGR of 6.5% during the forecast period of 2024-2032 to reach a value of USD 15.98 billion by 2032.

 

Aortic Valve Replacement Devices Market Outlook

  • Development of sutureless aortic valve replacement, increasing demand for minimally invasive surgical procedures, and further advancements in transcatheter aortic valve replacement (TAVR) are aiding the market.
  • Government-introduced reimbursement policies and insurance benefits, to financially support the patients intending to undergo AVR are increasing.
  • Reportedly, the number of individuals aged 65 years or older is anticipated to more than double, increasing from 761 million in 2021 to 1.6 billion in 2050.

 

Aortic Valve Replacement Devices Market Growth

To accelerate the adoption of aortic valve replacement devices in underdeveloped areas, stakeholders in the healthcare segment are focusing on improving the access of the population to interventional cardiology and cardiothoracic surgery specialities. In addition, a rise in educational campaigns to spread awareness regarding aortic valve diseases will increase the use of these devices in the treatment procedure.

 

As the number of elderly patients with aortic valve stenosis and various other comorbidities is growing, the adoption of less invasive therapies is increasing, as surgeries pose a significant risk to their life. Additionally, the expanding geriatric population in Asian countries is also expected to enhance the adoption of minimally invasive aortic valve replacement procedures.

 

Figure: World Population of the Elderly (In Million)

Aortic Valve Replacement Devices Market

 

Key Trends and Developments

Increasing aortic stenosis in geriatric population; adoption of advanced aortic valves to ease surgical procedures; rising sedentary lifestyles; and increasing cases of valvular heart diseases are impacting the aortic valve replacement devices market growth

 

Nov 9, 2022

Boston Scientific Corporation announced the launch of the LUX-Dx™ Insertable Cardiac Monitor (ICM) System, a long-term diagnostic device that is designed with a dual-stage algorithm and inserted under the patients’ skin for the detection and verification of arrhythmias associated with conditions such as atrial fibrillation (AF), cryptogenic stroke and syncope.

 

Sep 12, 2022

Edwards Lifesciences launched its next-gen Sapien 3 Ultra Resilia transcatheter heart valve, after its FDA approval. The latest TAVR device incorporates Resilia tissue technology that provides enhanced calcium blocking properties and dry tissue packaging conditions for facilitating the ease of usage.

 

Feb 15, 2022

Boston Scientific Corporation closed the acquisition of Baylis Medical Company Inc., a company offering guidewires, sheaths, dilators for supporting catheter-based left-heart procedures and advanced transseptal access solutions.

 

Jan 10, 2022

Medtronic announced that the National Medical Products Administration (NMPA) approved the CoreValve™ Evolut™ PRO TAVR system to treat severe aortic stenosis (AS) for symptomatic patients in China who are at high or extreme risk for open heart surgery.

 

Rising cases of aortic stenosis in geriatric population

Aortic stenosis is a common life-threatening heart valve disease that can result in heart failure. Geriatric population can depict severe, symptomatic aortic stenosis.

 

Advanced aortic valves to ease surgical procedures

Advanced aortic valves such as the sutureless aortic valve replacement (SU-AVR) and rapid deployment aortic valve replacement (RD-AVR) allow hospitals to conduct easy, effective, and safe valve implantation under direct vision.

 

Rising sedentary lifestyles and chronic diseases

The prevalence of chronic diseases, such as hypertension, cholesterol and diabetes, owing to people’s unhealthy and hectic lifestyle is increasing the risks of aortic valve failure and the need to replace it.

 

Increasing use in the treatment of various aortic valve diseases

Aortic valve replacement devices are used to treat conditions including aortic valve regurgitation, aortic valve stenosis, and other congenital heart defects that affect the aortic valve.

 

Aortic Valve Replacement Devices Market Trends

Aortic valve stenosis cases are increasing in numbers around the globe with a growing geriatric population and the prevalence of atherosclerosis. The geriatric population is highly susceptible to aortic valve conditions, particularly if they have cardiovascular risk factors such as high cholesterol and a history of smoking, which increase their chances for developing aortic valve calcification, requiring valve replacement. Patients aged 75 and above tend to have symptomatic and severe aortic stenosis and are investing in minimally invasive aortic valve replacement procedures to reduce their symptoms.

 

People aged 75 and above are inclined towards less invasive transcatheter aortic valve replacements as conducting an open-heart surgery on them is risky as they are weak and may be suffering from multiple other diseases.

 

Additionally, procedures such as the SU-AVR, minimally invasive aortic valve replacement (MIAVR), and transcatheter aortic valve implantation/transcatheter aortic valve replacement (TAVI/TAVR) are being used to overcome the shortcomings of surgical AVRs.

 

Heart defects such as aortic valves with missing valve openings, incorrect valve size or shape, or blood flowing backwards are increasing the need for aortic valve replacement devices. Some unhealthy habits include a sedentary lifestyle with little to no exercise, alcohol consumption beyond safety limits, excessive stress damaging heart valves, and having a diet high in salt.

 

Global Aortic Valve Replacement Devices Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Aortic Valve Replacement Devices Industry Segmentation

“Global Aortic Valve Replacement Devices Market Report and Forecast 2024-2032” offers a detailed analysis of the market based on the following segments:

 

Market Breakup by Surgery Type

  • Open Surgery
  • Minimally Invasive Surgery

 

Market Breakup by Product Type

  • Transcatheter Aortic Valve
  • Sutureless Aortic Valve Replacement (SUAVR) 

 

Market Breakup by End Use

  • Hospitals
  • Ambulatory Surgical Centres
  • Others

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Aortic Valve Replacement Devices Market Share

Based on surgery type, minimally invasive surgery accounts for a significant share of the market

Minimally invasive aortic valve replacement surgeries are preferred by people and healthcare professionals as they prevent excess blood loss during the surgery, involve a lower risk of infection, and leave relatively fewer scars on the patient's body as they involve smaller chest incisions compared to open-heart surgery.

 

Minimally invasive heart surgeries are associated with benefits like a shorter hospital stay, and faster recovery, and are less painful than the traditional methods.

 

Open-heart aortic valve replacement surgeries are advisable for patients who need to undergo multiple coronary bypass processes or complex cardiovascular operations.

 

Based on product type, TAVR significantly contributes to the global aortic valve replacement devices market revenue

The enhanced safety and fast recovery times offered by TAVR (transcatheter aortic valve replacement) have boosted its utilisation as an effective treatment for severe aortic stenosis among geriatric patients. Innovations in the design of valve prosthesis and technological advancements in its haemodynamic performance, along with the availability of data based on trials to establish the efficacy of TAVR, are expected to widen the scope of TAVR in low-risk and immediate patient groups.

 

Leading Companies in the Aortic Valve Replacement Devices Market

Market players are focusing on improving the availability of medical devices and delivering products that guarantee superior clinical outcomes

 

Boston Scientific Corporation

Headquartered in the United States, Boston Scientific Corporation is a manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties. The company’s core businesses are organized into three segments: Medsurg, Rhythm and Neuro, and Cardiovascular.

 

Corcym S.r.l.

An Italian company, Corcym is primarily engaged in the manufacture of medical devices for heart surgeries. The company was formed after the acquisition of the LivaNova PLC (LivaNova) heart valve business by Gyrus Capital (Gyrus) in June 2021.

 

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is primarily engaged in the manufacture of heart valve systems and repair products. The company manufactures transcatheter aortic valve replacement, transcatheter mitral and tricuspid technologies, and structural surgical heart products primarily in the United States (California and Utah), Singapore, Costa Rica, and Ireland.

 

Medtronic plc

Headquartered in Ireland, Medtronic is a global leader in the healthcare technology sector. The company is engaged in the manufacture, distribution, and sales of device-based medical therapies and services in the cardiovascular, medical-surgical, neuroscience, and diabetes operating segments.

 

Other notable players operating in the global aortic valve replacement devices market are Artivion, Inc, and Abbott Laboratories, among others.

 

Global Aortic Valve Replacement Devices Market by Region\

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Aortic Valve Replacement Devices Market Analysis by Region

North America is a key market for aortic valve replacement devices, with the US leading the way

North America remains a significant market, supported by the presence of advanced medical facilities, well-established healthcare infrastructure, and increasing geriatric population. In the United States, heart disease is the major cause of death for both men and women, and aortic stenosis, in particular, is one of the most common heart valve illnesses, affecting Americans over the age of 75 years. While surgical aortic valve replacement/implantation (SAVR, or SAVI) is the standard treatment for patients with severe aortic stenosis, transcatheter aortic valve replacement/implantation (TAVR, or TAVI) has established as a reliable and robust alternative for elderly patients who are at high risk for open surgery due to age, frailty, and other factors.

 

Meanwhile, the growing geriatric population and the rising incidences of aortic stenosis in the Asia Pacific have bolstered the use of TAVR in clinical practices owing to its minimally invasive procedure, fast recovery times, and low mortality rates.

 

The Japanese government has been providing grants for innovative sutureless aortic heart valve, and unlike various other Asian countries, the national government also funds TAVI, enhancing the domestic accessibility to versatile aortic valve replacement devices.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Surgery Type
  • Product Type
  • End User
  • Region
Breakup by Surgery Type
  • Open Surgery
  • Minimally Invasive Surgery
Breakup by Product Type
  • Transcatheter Aortic Valve 
  • Sutureless Aortic Valve Replacement (SUAVR)
Breakup by End User
  • Hospitals 
  • Ambulatory Surgical Centres 
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Boston Scientific Corporation
  • Corcym S.r.l
  • Edwards Lifesciences Corporation 
  • Medtronic plc 
  • Artivion, Inc.
  • Abbott Laboratories
  • Others

 

Read Our Top Selling Reports

India Disposable Medical Gloves Market

Latin America In-vitro Diagnostics Market

Global Implantable Medical Devices Market

Health Economics and Outcomes Research (HEOR) Market

Latin America Advanced Wound Care Market

Global Acute Kidney Injury Treatment Market

Global JE (Japanese Encephalitis) Vaccine Market

North America Laboratory Informatics Market

Global Laboratory Information System Market

South Africa Orthopaedic Braces and Supports Market

 

Aortic Valve Replacement Devices Market Report Snapshots

Aortic Valve Replacement Devices Market Size

Aortic Valve Replacement Devices Market Growth

Aortic Valve Replacement Devices Market Trends

Aortic Valve Replacement Devices Market Share

Aortic Valve Replacement Devices Companies

Aortic Valve Replacement Devices Market Regional Analysis

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Aortic Valve Replacement Devices Market Overview 

    3.1    Global Aortic Valve Replacement Devices Market Historical Value (2017-2023) 
    3.2    Global Aortic Valve Replacement Devices Market Forecast Value (2024-2032)
4    Global Aortic Valve Replacement Devices Market Landscape
    4.1    Global Aortic Valve Replacement Devices Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Aortic Valve Replacement Devices Product Landscape
        4.2.1    Analysis by Surgery Type
        4.2.2    Analysis by Product Type
5    Global Aortic Valve Replacement Devices Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Aortic Valve Replacement Devices Market Segmentation 
    6.1    Global Aortic Valve Replacement Devices Market by Surgery Type
        6.1.1    Market Overview 
        6.1.2    Open Surgery
        6.1.3    Minimally Invasive Surgery
    6.2    Global Aortic Valve Replacement Devices Market by Product Type    
        6.2.1    Market Overview
        6.2.2    Transcatheter Aortic Valve
        6.2.3    Sutureless Aortic Valve Replacement (SUAVR)
    6.3    Global Aortic Valve Replacement Devices Market by End User
        6.3.1    Market Overview
        6.3.2    Hospitals
        6.3.3    Ambulatory Surgical Centres
        6.3.4    Others
    6.4    Global Aortic Valve Replacement Devices Market by Region
        6.4.1    Market Overview
        6.4.2    North America 
        6.4.3    Europe
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Aortic Valve Replacement Devices Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Aortic Valve Replacement Devices Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Aortic Valve Replacement Devices Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Aortic Valve Replacement Devices Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Aortic Valve Replacement Devices Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Boston Scientific Corporation
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Corcym S.r.l
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Edwards Lifesciences Corporation
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Medtronic plc
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Artivion, Inc.
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Abbott Laboratories 
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Others
18    Global Aortic Valve Replacement Devices Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market reached a value of USD 8.99 billion in 2023.

The market is estimated to witness a CAGR of 6.5% during the forecast period of 2024-2032.

The market is estimated to witness a healthy growth in the forecast period of 2024-2032 to reach a value of USD 15.98 billion by 2032.

The surgical procedures include open surgery and minimally invasive surgery.

The key regional markets for aortic valve replacement devices are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The product types include transcatheter aortic valve and sutureless aortic valve replacement (SUAVR).

The key factors driving the market include increasing geriatric population, increased government funding, and improving healthcare infrastructure and services.

The key players in the market include Boston Scientific Corporation, Corcym S.r.l, Edwards Lifesciences Corporation, Medtronic plc, Artivion, Inc., and Abbott Laboratories, among others.

Analyst Review

 

 

 

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER